Community/Retail

Those recognized were selected by a panel of judges from more than 15,000 customer-submitted entries in October 2018, during American Pharmacists Month.

A study in 2008 showed that approximately 5.2% of US adults age 18-80 years used benzodiazepines.

Amber Draper, PharmD, BCOP, clinical pharmacist, Winship Cancer Institute in Georgia discusses educating patients about lifestyle and dietary factors that increase risk of colon cancer. This video was filmed at the 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, Texas.

Although the prevalence of LEMS in children is not known, the overall prevalence is estimated to be 3 per million individuals worldwide, according to the FDA.

When applying for the grant for Realo Discount Drug’s Transition to Wellness Program, Christina Nunemacher's goal was to show that involving pharmacists in the hospital discharge process could lower readmission rates.

Health care professionals provide their considerations regarding the future of measles prevention and management.

Prior to this approval, there were no available treatments for ATTR-CM, only symptom management and, in rare cases, heart transplant.

How did a man with low sperm county get his wife pregnant?

Dapagliflozin is a selective sodium‑glucose cotransporter-2 (SGLT-2) inhibitor that is combined with a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, saxagliptin; and metformin hydrochloride extended release.

Jaron Stout, PharmD, owner, consulting pharmacist, Collaborative Pharmacy Consultants, discusses collaborative practice agreements and how they vary between states. This video was filmed at the American Society of Consultant Pharmacists' 2019 Forum in Washington, DC.

Can omega 3 oils calm inflamation?

Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.

Dana Saffel, PharmD, CEO of Pharmacare Strategies, discusses various crushing systems and USP 800 compliance during the American Society of Consultant Pharmacists in Washington, DC.

In the first and largest study of its kind, researchers from the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute aimed to assess mortality associated with beta interferons for the treatment of MS.

The FDA rapidly reviewed and approved Genentech’s application under the FDA’s Real-Time Oncology Review (RTOR) and Assessment Aid pilot programs, leading to an approval 12 weeks after completing the submission.

Results of the recent study, published in The Lancet, support the benefits of early testing and treatment for HIV, as well as the message of Prevention Access Campaign’s U=U (undetectable equals untransmittable) initiative.

Lisa Holle, PharmD, BCOP, FHOPA, associate clinical professor at the University of Connecticut, explains the importance of patient-provider communication during the 2019 Hematology/Oncology Pharmacy Association conference in Fort Worth, Texas.

Measles cases are increasing at an alarming rate, and the antivaccination movement has helped bring back this potentially deadly disease that was once eliminated in the United States.

Teva Pharmaceutical Industries has launched a generic version of Gilead’s Letairis (ambrisentan) Tablets, 5 mg and 10 mg, in the United States.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The approved generic treatment is therapeutically equivalent to Novartis’ Pataday Ophthalmic Solution, 0.2%, according to Alembic.

The sNDA was granted Priority Review and accepted under the agency's Real-Time Oncology Review pilot program, which aims to make the review of oncology drugs more efficient by allowing the FDA access to clinical trial data before the information is formally submitted to the agency.

The influenza vaccine for the 2019-2020 flu season will look different than it has for the past few seasons.

The study authors believe that the modification of teriflunomide and the development of new DHODH inhibitors is urgent for drug-resistant epilepsy patients

During the 2019 American Society of Consultant Pharmacists (ASCP) Forum in Washington, DC, Johanna M. Thompson, PhamD, BCPS, BCGP, clinical pharmacist at Intermountain Healthcare, discusses one of the factors that drive pharmacists into the primary care field.

Using medications to induce calm is generally considered less desirable than other methods of de-escalation but is often necessary to prevent injury.

Dengue is endemic in the United States territories of American Samoa, Guam, Puerto Rico and the US Virgin Islands.

In this clip from the Hematology/Oncology Pharmacy Association, Alison Duffy, PharmD, BCOP, from the University of Maryland Greenbaum Comprehensive Cancer Center, shares important considerations in treating Chronic Lymphocytic Leukemia in patients.

A number of landmark clinical studies on lipid lowering and cardiovascular health have been published, shaping how patients are treated.

Dana Saffel, PharmD, CEO of PharmaCare Strategies, relays the challenges to USP 800 compliance during the American Society of Consultant Pharmacists Forum in Washington, DC.